Trade DCTH stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Delcath Systems, Inc. (DCTH) is trading at US$16.40, up 1.80% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$594.74M. Over the past 52 weeks, DCTH has traded between US$8.12 and US$17.42. On Syfe you can trade DCTH with $0 commission and add it to your watchlist.
| Previous close | US$16.11 |
|---|---|
| Market cap | US$594.74M |
| 52-week range | US$8.12 – US$17.42 |
| Volume | 368.43K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Delcath Systems, Inc.
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
Year: 2000
Delcath Systems Doses First Patient in Mid-Stage Trial of Hepzato
Jul 9, 12:44 PM · MT Newswires
Delcath Systems Publishes Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts
May 26, 9:23 PM · MT Newswires
Delcath Systems, Inc. (DCTH) stock is trading at US$16.40, +1.80% from the previous close of US$16.11.
The market cap for Delcath Systems, Inc. (DCTH) stock is approximately US$594.74M.
The 52-week high for Delcath Systems, Inc. (DCTH) stock is US$17.42.
The 52-week low for Delcath Systems, Inc. (DCTH) stock is US$8.12.
Delcath Systems, Inc. (DCTH) does not currently pay a dividend.
Stay on top of DCTH
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
